V G Sharov - JoVE Visualize

Showing results (71-80 of 81) with videos related to

Pageof 9

Sort By:

The American Journal of Physiology|January 1, 1996

Effects of ACE inhibition and beta-blockade on skeletal muscle fiber types in dogs with moderate heart failureH N Sabbah, H Shimoyama, V G Sharov, et al.

Circulation|June 1, 1994

Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fractionH N Sabbah, H Shimoyama, T Kono, et al.

Biokhimiia (Moscow, Russia)|December 1, 1976

[The functional coupling between MM isozyme of creatine phosphokinase (EC 2.7.3.2.) and MgATPase of myofibrils and (Na, K)ATPase of plasma membrane in heart cells]V A Saks, N V Lipina, G B Chernousova, et al.

The Journal of Thoracic and Cardiovascular Surgery|November 1, 1987

Protection of ischemic myocardium by exogenous phosphocreatine. II. Clinical, ultrastructural, and biochemical evaluationsM L Semenovsky, V I Shumakov, V G Sharov, et al.

Journal of Cardiac Surgery|January 5, 2002

Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failureP A Chaudhry, P V Anagnostopouls, T Mishima, et al.

Circulation|May 1, 1993

Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failureH N Sabbah, F Hansen-Smith, V G Sharov, et al.

Vestnik Akademii Meditsinskikh Nauk SSSR|January 1, 1991

[Phosphocreatine, tocopheryl phosphate and their combination in acute ischemia and myocardial reperfusion in dogs: the effect on rhythm disorders, left ventricle contractility and infarct size]E A Konorev, V A Saks, D V Rudnev, et al.

Biochemical Medicine and Metabolic Biology|February 1, 1986

Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic actionV G Sharov, N I Afonskaya, M Y Ruda, et al.

Biochemical Medicine|December 1, 1985

Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heartE K Seppet, A J Adoyaan, A P Kallikorm, et al.

Heart Failure Reviews|March 15, 2001

Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failureH N Sabbah, W Haddad, Y Mika, et al.

Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:

Pageof 9

The American Journal of Physiology|January 1, 1996

Effects of ACE inhibition and beta-blockade on skeletal muscle fiber types in dogs with moderate heart failureH N Sabbah, H Shimoyama, V G Sharov, et al.

Circulation|June 1, 1994

Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fractionH N Sabbah, H Shimoyama, T Kono, et al.

Biokhimiia (Moscow, Russia)|December 1, 1976

[The functional coupling between MM isozyme of creatine phosphokinase (EC 2.7.3.2.) and MgATPase of myofibrils and (Na, K)ATPase of plasma membrane in heart cells]V A Saks, N V Lipina, G B Chernousova, et al.

The Journal of Thoracic and Cardiovascular Surgery|November 1, 1987

Protection of ischemic myocardium by exogenous phosphocreatine. II. Clinical, ultrastructural, and biochemical evaluationsM L Semenovsky, V I Shumakov, V G Sharov, et al.

Journal of Cardiac Surgery|January 5, 2002

Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failureP A Chaudhry, P V Anagnostopouls, T Mishima, et al.

Circulation|May 1, 1993

Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failureH N Sabbah, F Hansen-Smith, V G Sharov, et al.

Vestnik Akademii Meditsinskikh Nauk SSSR|January 1, 1991

[Phosphocreatine, tocopheryl phosphate and their combination in acute ischemia and myocardial reperfusion in dogs: the effect on rhythm disorders, left ventricle contractility and infarct size]E A Konorev, V A Saks, D V Rudnev, et al.

Biochemical Medicine and Metabolic Biology|February 1, 1986

Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic actionV G Sharov, N I Afonskaya, M Y Ruda, et al.

Biochemical Medicine|December 1, 1985

Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heartE K Seppet, A J Adoyaan, A P Kallikorm, et al.

Heart Failure Reviews|March 15, 2001

Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failureH N Sabbah, W Haddad, Y Mika, et al.

Pageof 9